ESR1 and breast carcinoma: Their study showed that PROTAC 1 (Table 1) induces ERα degradation, reactive oxygen species (ROS) production, and necrotic cell death in estrogen-dependent breast cancer MCF-7 cells, with therapeutic potential for ERα-positive breast cancer.